Neuromyelitis optica: new findings on pathogenesis (Q33285946)

25 July 2017

1 reference

title

Neuromyelitis optica: new findings on pathogenesis (English)

1 reference

25 July 2017

0 references

1 reference

Dean M Wingerchuk

1 reference

25 July 2017

publication date

1 January 2007

1 reference

International Review of Neurobiology

25 July 2017

published in

1 reference

25 July 2017

1 reference

25 July 2017

page(s)

665-688

1 reference

Aquaporin water channels: molecular mechanisms for human diseases

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

The molecular basis of water transport in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Activation of humoral immunity and eosinophils in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

1 reference

7 January 2021

An open label study of the effects of rituximab in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

1 reference

7 January 2021

Devic's disease: bridging the gap between laboratory and clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Plasma exchange for severe attacks of CNS demyelination: predictors of response

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Neuromyelitis optica with unusual vascular changes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Sjögren's syndrome with acute transverse myelopathy as the initial manifestation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Absence of IgG1 response in the cerebrospinal fluid of relapsing neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Mechanisms of action of glatiramer acetate in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Clinical, CSF, and MRI findings in Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Neuromyelitis optica versus subacute necrotic myelitis. II. Anatomical study of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Brain abnormalities in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Neuromyelitis optica with hypothalamic involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

A mighty mouse: building a better model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

OSMS is NMO, but not MS: proven clinically and pathologically

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Neuromyelitis optica: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Evidence for humoral autoimmunity in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Neuromyelitis optica: clinical predictors of a relapsing course and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

1 reference

7 January 2021

The clinical course of neuromyelitis optica (Devic's syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Revised diagnostic criteria for neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979029-3

7 January 2021

10.1016/S0074-7742(07)79029-3

Identifiers

DOI

1 reference

25 July 2017

1 reference